76. Liquid biopsy

<p>In this episode, we dive into the potential of liquid biopsies as a method to detect deadly diseases. We speak with three experts – Marta Herreros, Rik Bryan, and Doug Ward – to learn more about the non-invasive nature of liquid biopsies and the process of detecting biomarkers within a patient sample. Rik and Doug discuss their GALEAS Bladder test, which can identify key mutations present in 96% of bladder cancer patients. Tune in to learn more about the potential of liquid biopsies and the importance of early detection!</p> <p><a href="https://www.cytivalifesciences.com/en/us/behind-biopharma/stories/liquid-biopsy-10002" target="_blank" rel="noopener noreferer">Transcript</a></p> <p><br></p> <p><strong>Show notes</strong></p> <ul> <li>GALEAS Bladder test – <a href="https://galeas.net/" target="_blank" rel="noopener noreferer">Galeas Bladder</a></li> <li>BBC and hybrid working – <a href="https://www.youtube.com/watch?v=6sxkykrngoE">Internal Communications Europe 2023 — BBC</a></li> <li>Identification by ears – <a href="https://www.sciencedirect.com/science/article/pii/S1286011523000620?via%3Dihub" target="_blank" rel="noopener noreferer">Ear identification: A multi-ethnic study sample - ScienceDirect</a></li> </ul> <p><strong>Keywords</strong>: <em>bladder cancer, patient, liquid biopsy, urine, cells, bladder, urine test, urine sample, mutations, tumor, DNA, cancer, clinical trials, sequencing, samples, biomarkers.</em></p>